Cargando…
Pediatric low-grade glioma: Targeted therapeutics and clinical trials in the molecular era
pLGGs are a group of tumors for which the era of molecular diagnostics has truly shifted treatment paradigms and patient care. The discovery that this group of tumors is driven by single-gene alterations/fusions in the MAPK pathway has resulted in relatively rapid translation into targeted therapy o...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Neoplasia Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803951/ https://www.ncbi.nlm.nih.gov/pubmed/36566593 http://dx.doi.org/10.1016/j.neo.2022.100857 |